UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
First lung disease reported here with suspected ties to vaping
by Lee Han-soo
2019-10-14 18:01
Drug regulator to hire 87 more reviewers next year
by Lee Hye-seon
2019-10-11 16:35
‘Direct-to-consumer genetic testing needs preparation’
by Kim Eun-young
2019-10-11 15:12
Korea to serve as WHO's executive country
by Lee Han-soo
2019-10-10 11:31
Korea, Latin America speed up expanding cooperation in healthcare
by Lee Han-soo
2019-10-08 18:04
라인
Korea, Peru compare notes on telemedicine
by Lee Han-soo
2019-10-08 15:20
Propofol abuse, addiction increasing at alarming rate
by Lee Han-soo
2019-10-07 17:56
Civic group protests regulator’s inaction over insulin pumps FDA recalled
by Lee Hye-seon
2019-10-07 16:10
Regulator under fire for neglecting reported side effects of Invossa
by Lee Han-soo
2019-10-04 14:59
Foreign patients visiting Korea rise by 17.8% in 2018
by Lee Han-soo
2019-10-02 17:50
라인
Authorities to test drugs of ranitidine family for carcinogen risk
by Lee Hye-seon
2019-10-02 14:51
Regulator raids cell therapy makers too often to little avail
by Jeong Sae-im
2019-10-02 11:23
Cost of smartphone-related illness tops ₩400 billion in 2018
by Lee Han-soo
2019-10-01 15:47
Will parliamentary audit uncover why Invossa was mislabeled?
by Jeong Sae-im
2019-10-01 15:45
Drug regulator under fire for going too far, too late
by Lee Han-soo
2019-09-27 17:48
라인
Foreign trainees satisfied with Lee Jong-wook Fellowship
by Choi Gwang-seok
2019-09-27 15:05
Regulator explained why it banned stomach medicine ranitidine altogether
by Jeong Sae-im
2019-09-27 15:02
Ranitidine heartburn drugs banned due to carcinogen risk
by Lee Hye-seon
2019-09-26 13:32
Korea, Uzbekistan speed up public health cooperation
by Kwak Sung-sun
2019-09-25 15:26
Ministry to announce results of ranitidine testing for carcinogen
by Lee Hye-seon
2019-09-25 14:46
-
이전
21
22
23
24
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top